Urinary Tract Infection Bacterial

3

Review clinical trials related to Urinary Tract Infection Bacterial. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Betadine vs Sterile Water for Periurethral Preparation

The purpose of this study is to determine whether cleaning of the urethra, or external opening to the bladder, with sterile water (water that has been treated to remove bacteria and living organisms) vs Betadine also known as Povidone-Iodine (a medical grade cleaning solution) changes the rates of bacteria in the urine after a temporary catheter, or draining tube, is placed into the bladder. Chemical antiseptics, including Betadine, are the current standard of care. An additional goal of this study is to determine whether cleaning of the urethra, or external opening to the bladder, with sterile water vs betadine changes the amount of discomfort or pain patients experience with placement of a temporary catheter, or draining tube, in the bladder.

Participants needed: 148
Trial details
Phase: Phase 4Age: 18+Biological sex: FemaleType: InterventionalSponsor: University of LouisvilleUpdated: May 4, 2026Locations: 2
Eligibility criteria

Aged 18+ [+1]

History of culture proven recurrent urinary tract infection (2 in any 6-month pe... [+6]

Status: Not yet recruiting

Relevance of the Urine Bacterial Culture Performed Before TransUrethral Resection of the Bladder for Post-operative Febrile Urinary Tract Infections Prevention: a Non-inferiority Randomized Controlled Trial

The main objective of the study is to demonstrate that not performing a systematic UC before the TURB procedure is non-inferior to performing a systematic UC in terms of the incidence of febrile UTIs during the first 30 postoperative days

Participants needed: 2,600
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Poitiers University HospitalUpdated: Apr 30, 2026Locations: 15
Eligibility criteria

Patient aged 18 or over [+3]

Patient with active UTI [+4]

Status: Recruiting

Shortened Antibiotic Treatment of 5 Days in Gram-negative Bacteremia

GNB5 is an investigator-initiated multicentre non-inferiority randomized controlled trial which aims to assess the efficacy and safety of shortened antibiotic for patients hospitalized with a Gram negative bacteremia with a urinary tract source of infection (GNB). Five days after initiation of antimicrobial therapy for GNB, participants are randomized 1:1 to parallel treatment arms: 5 days (intervention) or minimum 7 days (control) of antibiotic treatment. The intervention group discontinues antibiotics at day 5 if clinically stable and afebrile. The control group receives antibiotics for a duration of 7 days or longer at the discretion of the treating physician. The primary outcome is 90-day survival without clinical or microbiological failure to treatment, which will be tested with a non inferiority margin of 10%.

Participants needed: 380
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: Thomas BenfieldUpdated: Feb 8, 2023Locations: 13
Eligibility criteria

Age >18 years [+6]

Antibiotic treatment (>2 day) with antimicrobial activity to Gram-negative bacte... [+6]